NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Novo Nordisk securities between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EQIX.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Direct Digital Holdings Inc. ("Direct Digital" or "the Company") (NASDAQ:DRCT). Investors who purchased Direct Digital securities prior to April 17, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DRCT.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ:AKRO). Investors who purchased Akero securities prior to September 13, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AKRO.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ZYXI.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bitfarms Ltd. ("Bitfarms" or "the Company") (NASDAQ:BITF).

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solaris Energy Infrastructure, Inc. ("Solaris" or "the Company") (NYSE:SEI). Investors who purchased Solaris securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SEI.

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Affirm Holdings, Inc. ("Affirm" or "the Company") (NASDAQ:AFRM). Investors who purchased Affirm securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AFRM.

LONDON, March 20, 2025 (GLOBE NEWSWIRE) -- Willis, a WTW business, (NASDAQ:WTW), has announced the appointment of Kate Harb as Global Data Strategy Leader and Dermot Sargent as Global Digital Platforms Leader. Both appointments form part of Willis' ongoing commitment to digitization and the delivery of a market-leading and innovative data-driven strategy.

Although its 2021 initial public offering (IPO) attracted plenty of attention, Lucid Motors has seen consistent struggles with profitability and production thus far.

Nvidia CEO Jensen Huang praised the Trump administration's AI policies in an FT interview and said he sees the company spending hundreds of billions on U.S.-made electronics.

Investors need to pay close attention to Hillenbrand (HI) stock based on the movements in the options market lately.

USCB Financial (USCB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Sun Life stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Manhattan Associates To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you purchased or acquired securities in Manhattan Associates between October 22, 2024 and January 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Manhattan …

I maintain a strong buy rating for MSTR, projecting a 20X increase in market cap over the next decade due to its evolving role as Bitcoin's investment bank. Strategy's issuance of preferred shares (STRK and STRF) strengthens my thesis that it channels BTC through its capital structure, creating BTC-backed securities. MSTR benefits from BTC volatility by monetizing it, increasing BTC per share, and generating a BTC Yield, despite potential risks in a bear market.

Atlassian's focus on large enterprises and non-technical customers aims to drive sustainable long-term growth and reduce customer acquisition costs. The company's extensive data and AI integration provide a competitive edge, uncovering market opportunities unseen by competitors. Competitive pressures cloud migration risks, and high expectations might deter more conservative investors.

ALBANY, N.Y. , March 20, 2025 /PRNewswire/ -- M&T Bank (NYSE: MTB) has announced Charles Pinckney, Regional President for Albany, will take on the additional responsibility of Regional President for M&T Bank's Hudson Valley region.